Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2
Lin Yang,1,2 Xiaoyu Pan,2 Zhenyu Pan,3 Haina Gao,4 Jiangli Ban,4 Shuchun Chen2,5,6 1Department of Internal Medicine, Hebei North University, Zhangjiakou, Hebei, People's Republic of China; 2Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China...
Saved in:
Main Authors: | Yang L (Author), Pan X (Author), Pan Z (Author), Gao H (Author), Ban J (Author), Chen S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
by: Pan X, et al.
Published: (2022) -
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
by: Chen X, et al.
Published: (2022) -
Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
by: Wen-Bei Liu, et al.
Published: (2022) -
Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1
by: Yinliang Zhang, et al.
Published: (2017) -
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
by: Xiaoyi Chen, et al.
Published: (2023)